Early-onset alopecia and amyotrophic lateral sclerosis: A cohort study

American Journal of Epidemiology

Volumn 178, Issue 7, 2013, Pages 1146-1149

  Fondell, Elinor ^a   Fitzgerald, Kathryn C ^a   Falcone, Guido J ^a,b   O'Reilly, Éilis J ^a   Ascherio, Alberto ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

alopecia; amyotrophic lateral sclerosis; cohort studies; male pattern baldness; motor neuron disease

Indexed keywords

COHORT ANALYSIS; EPIDEMIOLOGY; HAIR; MENS HEALTH; META-ANALYSIS; PROTEIN; RISK ASSESSMENT;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA;

ALOPECIA; AMYOTROPHIC LATERAL SCLEROSIS; COHORT STUDIES; MALE-PATTERN BALDNESS; MOTOR NEURON DISEASE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALOPECIA; AMYOTROPHIC LATERAL SCLEROSIS; COHORT STUDIES; DNA-BINDING PROTEINS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

UNITED STATES;

EID: 84884943866     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwt096     Document Type: Article

References (25)

1. del Aguila MA, Longstreth WT Jr, McGuire V, et al. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology. 2003;60(5):813-819.
2. Traynor BJ, Codd MB, Corr B, et al. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology. 1999;52(3):504-509.
3. Armon C. Sports and trauma in amyotrophic lateral sclerosis revisited. J Neurol Sci. 2007;262(1-2):45-53.
4. Weiner LP. Possible role of androgen receptors in amyotrophic lateral sclerosis. A hypothesis. Arch Neurol. 1980;37(3): 129-131.
5. La Spada AR,Wilson EM, Lubahn DB, et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352(6330):77-79.
6. Bruson A, Sambataro F, Querin G, et al. CAG repeat length in androgen receptor gene is not associated with amyotrophic lateral sclerosis. Eur J Neurol. 2012;19(10):1373-1375.
7. Zhuo FL, XuW,Wang L, et al. Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis. Clin Exp Dermatol. 2012;37(2):104-111.
8. Inui S, Itami S. Molecular basis of androgenetic alopecia: From androgen to paracrine mediators through dermal papilla. J Dermatol Sci. 2011;61(1):1-6.
9. Li R, Brockschmidt FF, Kiefer AK, et al. Six novel susceptibility loci for early-onset androgenetic alopecia and their unexpected association with common diseases. PLoS genetics. 2012;8(5):e1002746.
10. Rimm EB, Giovannucci EL,Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 1991;338(8765):464-468.
11. Norwood OT. Male pattern baldness: classification and incidence. South Med J. 1975;68(11):1359-1365.
12. Brooks OT, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293-299.
13. Weisskopf MG, McCullough ML, Calle EE, et al. Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol. 2004;160(1):26-33.
14. Wang H, OReilly EJ, Weisskopf MG, et al. Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts. Arch Neurol. 2011;68(2):207-213.
15. Su LH, Chen TH. Association of androgenetic alopecia with smoking and its prevalence among Asian men: a community-based survey. Arch Dermatol. 2007;143(11): 1401-1406.
16. OReilly EJ,Wang H, Weisskopf MG, et al. Premorbid body mass index and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013; 14(3):205-211.
17. Wang H, OReilly EJ, Weisskopf MG, et al. Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studies. Am J Epidemiol. 2011;173(6):595-602.
18. Blasco H, Guennoc AM, Veyrat-Durebex C, et al. Amyotrophic lateral sclerosis: a hormonal condition? Amyotroph Lateral Scler. 2012;13(6):585-588.
19. Vivekananda U, Manjalay ZR, Ganesalingam J, et al. Low index-To-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability. J Neurol Neurosurg Psychiatry. 2011;82(6):635-637.
20. Wicks P. Hypothesis: higher prenatal testosterone predisposes ALS patients to improved athletic performance and manual professions. Amyotroph Lateral Scler. 2012;13(3):251-253.
21. Johnson AD, Handsaker RE, Pulit SL, et al. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics. 2008;24(24): 2938-2939.
22. Yokoseki A, Shiga A, Tan CF, et al. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol. 2008; 63(4):538-542.
23. Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:3.
24. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796): 130-133.
25. Van Deerlin VM, Leverenz JB, Bekris LM, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008;7(5):409-416.